[-(2,2,3,3-tetramethylcyclopropyl)methanone: A new synthetic cannabinoid identified on the drug market

Forensic Toxicology

Volumn 31, Issue 2, 2013, Pages 281-291

  Zuba, Dariusz ^a   Geppert, Bogna ^b   Sekuła, Karolina ^a   Żaba, Czesław ^b  

^a INSTITUTE OF FORENSIC RESEARCH   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

A 834,735; Herbal highs; LC ESI QTOF MS; NMR identification; Synthetic cannabinoid; 1 (Tetrahydropyran 4 ylmethyl) 1H indol 3 yl (2,2,3,3 tetramethylcyclopropyl)methanone

Indexed keywords

CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR AGONIST; CANNABINOID DERIVATIVE; DRONABINOL; ILLICIT DRUG; UNCLASSIFIED DRUG; [1 (TETRAHYDROPYRAN 4 YLMETHYL) 1H INDOL 3 YL] (2,2,3,3 TETRAMETHYLCYCLOPROPYL)METHANONE;

ARTICLE; BINDING AFFINITY; DRUG IDENTIFICATION; DRUG TRAFFIC; ELECTRON IONIZATION MASS SPECTROMETRY; ELECTROSPRAY MASS SPECTROMETRY; GAS CHROMATOGRAPHY; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATENT; POLAND; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RECEPTOR BINDING; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84879794885     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-013-0191-8     Document Type: Article

References (34)

1. EMCDDA and Europol (2012) EU drug markets report: a strategic analysis. Publications Office of the European Union, Luxembourg
2. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreiros N (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832-837
3. EMCDDA (2011) Online sales of new psychoactive substances/'legal highs': summary of results from the 2011 multilingual snapshots. European Monitoring Centre for Drugs and Drug Addiction, Lisbon
4. EMCDDA (2012) Statistical bulletin 2012. European Monitoring Centre for Drugs and Drug Addiction, Lisbon
5. Zuba D, Byrska B (2012) Prevalence and co-existence of active components of 'legal highs'. Drug Test Anal. doi: 10.1002/dta.1365
6. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y (2013) Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012. Forensic Toxicol 31:44-53
7. Auwärter V, Kneisel S, Hutter M, Thierauf A (2012) Synthetische Cannabinoide. Rechtsmedizin 22:259-271
8. Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicol 29:95-110
9. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2011) Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol 29:25-37
10. 35 S]GTPγS binding assays. Forensic Toxicol 29:132-141
11. Nakajima J, Takahashi M, Seto T, Yoshida M, Kanai C, Suzuki J, Hamano T (2012) Identification and quantitation of two new naphthoylindole drugs-of-Abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated "herbal" products circulated in the Tokyo area. Forensic Toxicol 30:33-44
12. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2012) Identification of two new-type synthetic cannabinoids, N-(1-Adamantyl)-1-pentyl-1H-indole-3- carboxamide (APICA) and N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicol 30:114-125
13. Kneisel S, Bisel P, Brecht V, Broecker S, Müller M, Auwärter V (2012) Identification of the cannabimimetic AM-1220 and its azepane isomer (N-methylazepan-3-yl)-3-(1-naphthoyl)indole in a research chemical and several herbal mixtures. Forensic Toxicol 30:126-134
14. Moosmann B, Kneisel S, Girreser U, Brecht V, Westphal F, Auwärter V (2012) Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system. Forensic Sci Int 220:e17-e22
15. Uchiyama N, Matsuda S, Wakana D, Kikura-Hanajiri R, Goda Y (2013) New cannabimimetic indazole derivatives, N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1- pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-Amino-3-methyl-1-oxobutan- 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products. Forensic Toxicol 31:93-100
16. Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (2013) Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol. doi: 10.1007/s11419-013-0182-9
17. Choi H, Heo S, Kim E, Hwang BY, Lee C, Lee J (2013) Identification of (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone and its 5-pentyl fluorinated analog in herbal incense seized for drug trafficking. Forensic Toxicol 31:86-92
18. Kavanagh P, Grigoryev A, Savchuk S, Mikhura I, Formanovsky A (2013) UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products. Drug Test Anal. doi: 10.1002/dta.1456
19. Huffman JW, Dai D (1994) Design, synthesis and pharmacology of cannabimimetic indoles. Bioorg Med Chem Lett 4:563-566
20. Huffman JW, Padgett LW (2005) Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr Med Chem 12:1395-1411
21. Eissenstat MA, Bell MR, D'Ambra TE, Alexander EJ, Daum SJ, Ackerman JH, Gruett MD, Kumar V, Estep KG (1995) Aminoalkylindoles: structure-Activity relationships of novel cannabinoid mimetics. J Med Chem 38:3094-3105
22. 2 cannabinoid receptors and metabolic stability. J Med Chem 41:5353-5361
23. 2 cannabinoid receptor activity. J Med Chem 51:1904-1912
24. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2013) URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci Int 227:21-32
25. 2 agonists in the management of pain. Recent Pat CNS Drug Discov 7:4-24
26. Willis PG, Pavlova OA, Chefer SI, Vaupel DB, Mukhin AG, Horti AG (2005) Synthesis and structure-Activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography. J Med Chem 48:5813-5822
27. 2 receptor agonist exhibiting analgesic activity in rodent pain models. Br J Pharmacol 153:390-401
28. 2 ligands. Curr Pharm Design 15:3345-3366
29. Sekuła K, Zuba D, Stanaszek R (2012) Identification of naphthoylindoles acting on cannabinoid receptors based on their fragmentation patterns under ESI-QTOFMS. J Mass Spectrom 47:632-643
30. Wong HNC, Hon MY, Tse CW, Yip YC, Tanko J, Hudlicky T (1989) Use of cyclopropanes and their derivatives in organic synthesis. Chem Rev 89:165-198
31. Coates J (2000) Interpretation of infrared spectra: a practical approach. In: Meyers RA (ed) Encyclopedia of analytical chemistry. Wiley, Chichester, pp 10815-10837
32. Mauler F, Mittendorf J, Horváth E, De Vry J (2002) Characterization of the diarylether sulfonylester (-)-(R)-3-(2- hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties. J Pharmacol Exp Ther 302:359-368
33. Frost JM, Dart MJ, Tietje KR, Garrison TR, Grayson GK, Daza AV, El-Kouhen OF, Yao BB, Hsieh GC, Pai M, Zhu CZ, Chandran P, Meyer MD (2010) Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. J Med Chem 53:295-315
34. http://www.drugs-forum.com/forum/showthread.php?t=176049&highlight= A-834%2C735. Accessed March 2013